Medline MDLN
NASDAQ MDLN
$39.68 -0.08 (-0.20%)
As of: Nov 6, 2026 · 3:59 PM EST

Medline (MDLN) Cash & Equivalents (2024 - 2026)

Updated

Medline's Cash & Equivalents came in at $2.32 billion for Q3 2026, down 0.3% from the prior quarter.

Analysis

Medline (MDLN) Cash & Equivalents (2024 - 2026) Analysis & Trends

At the end of FY2025, Medline's Cash & Equivalents was $1.94 billion, up 874.4% from FY2024.

  • Going back by year, Cash & Equivalents was $199 million in FY2024.
  • The five-year range for quarterly Cash & Equivalents is $199 million (Q4 2024) to $2.33 billion (Q2 2026).
  • Business Quant data shows MDLN's Cash & Equivalents at $2.33 billion (Q2 2026), $2.24 billion (Q1 2026) and $1.94 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Thermo Fisher Scientific 257.79 Bn 234.30 Bn 5.13 Bn 5.46 Bn
2 Abbott Laboratories 190.83 Bn 164.70 Bn 7.39 Bn 4.05 Bn
3 Danaher 162.10 Bn 141.75 Bn 3.84 Bn 5.68 Bn
4 Intuitive Surgical 158.05 Bn 138.34 Bn 2.08 Bn 2.98 Bn
5 Medtronic 130.31 Bn 95.56 Bn 6.34 Bn 1.69 Bn
6 Stryker 124.76 Bn 110.95 Bn 4.25 Bn 3.27 Bn
7 Boston Scientific 62.03 Bn 57.46 Bn 3.43 Bn 609.00 Mn
8 Edwards Lifesciences 58.73 Bn 41.94 Bn 1.35 Bn 3.11 Bn
9 Becton Dickinson 58.33 Bn 55.48 Bn 2.32 Bn 708.00 Mn
10 Medline 34.73 Bn 24.27 Bn 1.93 Bn 2.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 26, 2026 2.32 Bn
Jun 27, 2026 2.33 Bn
Mar 28, 2026 2.24 Bn
Dec 31, 2025 1.94 Bn
Dec 31, 2024 199.00 Mn
API Access

Medline Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=MDLN&period=max&api_key=YOUR_API_KEY